| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytokinetics, Incorporated (CYTK) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. CYTK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $31.69M | - | |
| VP | 141.5K | $11.21M | - | |
| Other | 87.3K | $6.91M | - | |
| VP | 73.6K | $5.82M | -15,000 | |
| CFO | 70.1K | $5.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $56.77 | $414,401.00 | -2.9% | -12.7% | -15.3% | |
| Sep 16, 2024 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $55.99 | $279,950.00 | -1.2% | -13.6% | -12.3% | |
| Sep 9, 2024 | Parshall B Lynne74 | Director | Sale+OE | 5,000 | $54.92 | $274,600.00 | -19.5% | -9.5% | -7.8% | |
| Sep 3, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,384 | $57.01 | $420,973.16 | -2.9% | -7.2% | -8.4% | |
| Sep 3, 2024 | Blum Robert I51 | President &CEO | Sale+OE | 5,000 | $57.03 | $285,150.00 | -1.2% | -7.2% | -8.4% | |
| Aug 26, 2024 | Parshall B Lynne74 | Director | Sale+OE | 5,000 | $57.26 | $286,300.00 | -19.5% | -12.0% | -33.1% | |
| Aug 20, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $56.25 | $410,638.00 | -2.8% | -8.6% | -34.4% | |
| Aug 12, 2024 | Parshall B Lynne74 | Director | Sale+OE | 5,000 | $55.20 | $276,000.00 | -19.5% | +4.3% | -38.9% | |
| Aug 12, 2024 | Blum Robert I51 | President &CEO | Sale+OE | 11,500 | $55.17 | $634,455.00 | -2.8% | +4.3% | -38.9% | |
| Aug 6, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $53.71 | $392,090.00 | -2.9% | -3.8% | -34.4% |